Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 5868-5875, September 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daly, R. J.
Right arrow Articles by Darbre, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daly, R. J.
Right arrow Articles by Darbre, P. D.

Cellular and Molecular Events in Loss of Estrogen Sensitivity in ZR-75-1 and T-47-D Human Breast Cancer Cells

R. J. Daly and Philippa D. Darbre1

Cellular Endocrinology Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, Box 123, London WC2A 3PX, England

When deprived of steroid in the long term, both estrogen-dependent (ZR-75-1) and estrogen-responsive (T-47-D) human breast cancer cells lose estrogen regulation of cell growth in a reproducible time course using both stock lines and recloned cells. The estrogen-stimulated growth rate was unaffected by such treatment, but there was an increase in the basal growth rate without steroid. For ZR-75-1 cells, the effects are clonal but occur at high frequency (1 in 1000 cells) and synchronously between clones, suggesting a phenotypic mechanism. These changes in cell growth occur without any coordinated loss of estrogen sensitivity of molecular markers (pS2 mRNA, progesterone receptor protein) showing that functional estrogen receptors remain present throughout. The constitutive expression of progesterone receptor in one clone of steroid-deprived ZR-75-1 cells does suggest, however, that alterations in expression of individual estrogen-sensitive genes can occur. Loss of estrogen-stimulated growth was not accompanied by loss of growth inhibition by antiestrogen, and the latter effect remained reversible by estradiol.

In an attempt to understand the molecular mechanisms underlying the loss of steroid sensitivity in the two cell lines, growth factor gene expression was investigated. Progression to steroid autonomy in T-47-D cells was accompanied by an upregulation of transforming growth factor (TGF) {alpha}, TGFß1, and TGFß2 mRNA. However, TGFß1 mRNA was downregulated in two ZR-75-1 steroid-deprived clones. These findings are discussed in relation to possible autocrine mechanisms in the loss of steroid sensitivity of breast cancer cells.

1 To whom reprint requests should be addressed.

Received 2/22/90. Accepted 6/14/90.




This article has been cited by other articles:


Home page
J EndocrinolHome page
D Pugazhendhi, K A Watson, S Mills, N Botting, G S Pope, and P D Darbre
Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells
J. Endocrinol., June 1, 2008; 197(3): 503 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Stephen, L. E. Shaw, C. Larsen, D. Corcoran, and P. D. Darbre
Insulin-like Growth Factor Receptor Levels Are Regulated by Cell Density and by Long Term Estrogen Deprivation in MCF7 Human Breast Cancer Cells
J. Biol. Chem., October 19, 2001; 276(43): 40080 - 40086.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. McClelland, D. Barrow, T.-A. Madden, C. M. Dutkowski, J. Pamment, J. M. Knowlden, J. M. W. Gee, and R. I. Nicholson
Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)
Endocrinology, July 1, 2001; 142(7): 2776 - 2788.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W.-S. Shim, M. Conaway, S. Masamura, W. Yue, J.-P. Wang, R. Kumar, and R. J. Santen
Estradiol Hypersensitivity and Mitogen-Activated Protein Kinase Expression in Long-Term Estrogen Deprived Human Breast Cancer Cells in Vivo
Endocrinology, January 1, 2000; 141(1): 396 - 405.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Gutman, S. Couillard, F. Labrie, B. Candas, and C. Labrie
Effects of the Antiestrogen EM-800 (SCH 57050) and Cyclophosphamide Alone and in Combination on Growth of Human ZR-75-1 Breast Cancer Xenografts in Nude Mice
Cancer Res., October 1, 1999; 59(20): 5176 - 5180.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-H. Jeng, M. A. Shupnik, T. P. Bender, E. H. Westin, D. Bandyopadhyay, R. Kumar, S. Masamura, and R. J. Santen
Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells
Endocrinology, October 1, 1998; 139(10): 4164 - 4174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.